Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
BROOKS LABORATORIES LTD.
Brooks Laboratories Ltd.
NSE: BROOKS | BSE: 533543
Expensive Performer
Download real time
157.76
3.09
(
2.00
%)
92.39% Gain from 52W Low
14,180
NSE+BSE Volume
NSE
15 Jul, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(3)
About
Brooks Laboratories Ltd. - BROOKS, 533543 corporate action history
Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Brooks Laboratories Ltd.
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
Brooks Laboratories Ltd. Bonus history
Brooks Laboratories Ltd. has not announced any bonus since Jan 1, 2000.
See all forthcoming Bonus and Splits
Brooks Laboratories Ltd. Split history
Brooks Laboratories Ltd. has not split the face value of the share since Jan 1, 2000.
See all forthcoming Bonus and Splits
Brooks Laboratories Ltd. Dividend history
Brooks Laboratories Ltd. has not given any dividends since Jan 1, 2000.
See all forthcoming dividends
Board Meetings - Brooks Laboratories Ltd.
The latest board meeting for Brooks Laboratories Ltd. took place on 28 May 2025, for the purpose of Audited Results
Ex-Date
Purpose
Notes
28 May 2025
Audited Results
-
13 Feb 2025
Quarterly Results
-
11 Dec 2024
To consider Fund Raising & Others
Inter-alia, to consider and approve 1. Proposal for Raising Funds through the issuance of securities (Equity Shares) by way of a preferential issue. 2. To approve the EGM. 3. Other business matters.
09 Nov 2024
Quarterly Results
-
14 Aug 2024
Quarterly Results
-
18 May 2024
Audited Results
-
31 Jan 2024
Quarterly Results
-
24 Jan 2024
Rights & Preferential issue
-
09 Nov 2023
Quarterly Results
-
10 Aug 2023
Quarterly Results
-
See all Board Meetings for Brooks Laboratories Ltd.
Rights history for Brooks Laboratories Ltd.
Brooks Laboratories Ltd. issued rights 2 times since Feb. 11, 2020. Brooks Laboratories Ltd. had last issued Rights shares of ₹10.0/- in the ratio of 1.0:16.0 @ premium of ₹65.0/- on July 28, 2023.
Ex-Date
Ratio
Face Value
Premium
Record Date
28 Jul 2023
1.0:16.0
10.0
65.0
28 Jul 2023
11 Feb 2020
9.0:20.0
10.0
10.0
12 Feb 2020
See all Rights History for Brooks Laboratories Ltd.